KYTHERA is a privately-held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic market.

KYTHERA has a robust pipeline, with clinical programs in adipolysis, facial contouring and pigmentation modulation and research programs in photoaging, topical neuromodulation and prevention of hair loss.